Procurement Summary
Country : Germany
Summary : Conclusion of a Non-exclusive Discount Agreement According to Section 130a (8) Sgb V for the Active Ingredient Adalimumab
Deadline : 10 Nov 2022
Other Information
Notice Type : Tender
TOT Ref.No.: 49404458
Document Ref. No. : 027691-2021
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Purchaser : GWQ SERVICEPLUS AG
Address: acting for the statutory health insurance companies mentioned in detail under VI 2.)
Town: Düsseldorf
NUTS code: DE - GERMANY
Postal Code: 40474
Phone: +49 211758498-0
Fax: +49 211758498-48
Germany
Email :bieteranfrage@gwq-serviceplus.de
URL :http://www.gwq-serviceplus.de
Tender Details
Document Type: Corrigendum / Additional information (Please refer tender document)
Title: Conclusion of a non-exclusive discount agreement in accordance with Section 130a, Paragraph 8 of Book V of the Social Code (SGB V) for the active ingredient Adalimumab
Reference Number: 2021 / S 013-027691
Contract Type: Supplies
Description: Section 130a, Paragraph 8 of Book V of the Social Code enables the health insurances (KK) and pharmaceutical companies to conclude framework discount agreements on the drugs to be dispensed at the expense of the statutory KK. GWQ acts as a company for efficiency and quality at KK in accordance with Section 130a, Paragraph 8, Sentence 5 of the Social Security Code (SGBV) for its shareholder and customer accounts. With regard to the relevant legal regulations for the award of public contracts, a regular process of active substance-related, formal award procedures according to the regulations of the 4th part of the GWB takes place by GWQ ServicePlus AG. Until new drug discount agreements come into effect, GWQ would like to conclude drug discount agreements with all interested pharmaceutical companies as part of the open-house procedure for preparations with the active ingredient adalimumab. The earliest contract start is January 1, 2021.
33600000 - Pharma ...
Documents
Tender Notice